Last modified by Sarantis Dimitriadis on 2023/12/08 13:20
From version 5.3
edited by Sarantis Dimitriadis
on 2022/06/02 09:58
Change comment: There is no comment for this version
To version 5.2
edited by Sarantis Dimitriadis
on 2022/06/02 09:50
Change comment: There is no comment for this version

Summary

Details

Page properties
Content
... ... @@ -89,14 +89,14 @@
89 89  (% lang="en-US" %)Typical approaches to define (%%)non-professional end users (a.k.a. study participants) in health and wellbeing living lab projects are presented in Table .
90 90  
91 91  
92 -(% cellspacing="0" class="table-hover" style="margin-left:auto; margin-right:auto" %)
92 +(% cellspacing="0" style="margin-left:auto; margin-right:auto" %)
93 93  |(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:5px; padding:0in 0.08in; width:628px" %)(((
94 94  (% class="western" lang="en-GB" style="text-align:center" %)
95 -(% lang="en-US" style="font-family:Calibri,serif" %)**Age or age group**
95 +(% style="font-family:Calibri,serif" lang="en-US" %)**Age or age group**
96 96  )))
97 97  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
98 98  (% class="western" lang="en-GB" %)
99 -(% lang="en-US" style="font-family:Calibri,serif" %)Specific age range
99 +(% style="font-family:Calibri,serif" lang="en-US" %)Specific age range
100 100  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
101 101  (% class="western" %)
102 102  
... ... @@ -109,16 +109,16 @@
109 109  )))
110 110  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
111 111  (% class="western" lang="en-GB" %)
112 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly
112 +(% style="font-family:Calibri,serif" lang="en-US" %)Elderly
113 113  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
114 114  (% class="western" lang="en-GB" %)
115 -(% lang="en-US" style="font-family:Calibri,serif" %)Adults
115 +(% style="font-family:Calibri,serif" lang="en-US" %)Adults
116 116  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
117 117  (% class="western" lang="en-GB" %)
118 -(% lang="en-US" style="font-family:Calibri,serif" %)Youth
118 +(% style="font-family:Calibri,serif" lang="en-US" %)Youth
119 119  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
120 120  (% class="western" lang="en-GB" %)
121 -(% lang="en-US" style="font-family:Calibri,serif" %)Children
121 +(% style="font-family:Calibri,serif" lang="en-US" %)Children
122 122  )))
123 123  |(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
124 124  (% class="western" %)
... ... @@ -135,20 +135,20 @@
135 135  )))
136 136  |(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
137 137  (% class="western" lang="en-GB" style="text-align:center" %)
138 -(% lang="en-US" style="font-family:Calibri,serif" %)**Health status**
138 +(% style="font-family:Calibri,serif" lang="en-US" %)**Health status**
139 139  )))
140 140  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
141 141  (% class="western" lang="en-GB" %)
142 -(% lang="en-US" style="font-family:Calibri,serif" %)Healthy
142 +(% style="font-family:Calibri,serif" lang="en-US" %)Healthy
143 143  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
144 144  (% class="western" lang="en-GB" %)
145 -(% lang="en-US" style="font-family:Calibri,serif" %)Patient
145 +(% style="font-family:Calibri,serif" lang="en-US" %)Patient
146 146  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
147 147  (% class="western" lang="en-GB" %)
148 -(% lang="en-US" style="font-family:Calibri,serif" %)Rehabilitant
148 +(% style="font-family:Calibri,serif" lang="en-US" %)Rehabilitant
149 149  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
150 150  (% class="western" lang="en-GB" %)
151 -(% lang="en-US" style="font-family:Calibri,serif" %)Recovered/Survivor
151 +(% style="font-family:Calibri,serif" lang="en-US" %)Recovered/Survivor
152 152  )))
153 153  |(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
154 154  (% class="western" %)
... ... @@ -165,75 +165,75 @@
165 165  )))
166 166  |(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
167 167  (% class="western" lang="en-GB" style="text-align:center" %)
168 -(% lang="en-US" style="font-family:Calibri,serif" %)**A specific disease, disorder or disability**
168 +(% style="font-family:Calibri,serif" lang="en-US" %)**A specific disease, disorder or disability**
169 169  )))
170 170  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
171 171  (% class="western" lang="en-GB" %)
172 -(% lang="en-US" style="font-family:Calibri,serif" %)ADHD
172 +(% style="font-family:Calibri,serif" lang="en-US" %)ADHD
173 173  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
174 174  (% class="western" lang="en-GB" %)
175 -(% lang="en-US" style="font-family:Calibri,serif" %)Dementia
175 +(% style="font-family:Calibri,serif" lang="en-US" %)Dementia
176 176  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
177 177  (% class="western" lang="en-GB" %)
178 -(% lang="en-US" style="font-family:Calibri,serif" %)Parkinsons’ disease
178 +(% style="font-family:Calibri,serif" lang="en-US" %)Parkinsons’ disease
179 179  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
180 180  (% class="western" lang="en-GB" %)
181 -(% lang="en-US" style="font-family:Calibri,serif" %)Loneliness and Social Isolation
181 +(% style="font-family:Calibri,serif" lang="en-US" %)Loneliness and Social Isolation
182 182  )))
183 183  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
184 184  (% class="western" lang="en-GB" %)
185 -(% lang="en-US" style="font-family:Calibri,serif" %)Autism
185 +(% style="font-family:Calibri,serif" lang="en-US" %)Autism
186 186  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
187 187  (% class="western" lang="en-GB" %)
188 -(% lang="en-US" style="font-family:Calibri,serif" %)Down syndrome
188 +(% style="font-family:Calibri,serif" lang="en-US" %)Down syndrome
189 189  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
190 190  (% class="western" lang="en-GB" %)
191 -(% lang="en-US" style="font-family:Calibri,serif" %)Physical disability
191 +(% style="font-family:Calibri,serif" lang="en-US" %)Physical disability
192 192  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
193 193  (% class="western" lang="en-GB" %)
194 -(% lang="en-US" style="font-family:Calibri,serif" %)Mental health
194 +(% style="font-family:Calibri,serif" lang="en-US" %)Mental health
195 195  )))
196 196  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
197 197  (% class="western" lang="en-GB" %)
198 -(% lang="en-US" style="font-family:Calibri,serif" %)Cardiovascular disease
198 +(% style="font-family:Calibri,serif" lang="en-US" %)Cardiovascular disease
199 199  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
200 200  (% class="western" lang="en-GB" %)
201 -(% lang="en-US" style="font-family:Calibri,serif" %)Idiopathic pulmonary fibrosis (IPF)
201 +(% style="font-family:Calibri,serif" lang="en-US" %)Idiopathic pulmonary fibrosis (IPF)
202 202  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
203 203  (% class="western" lang="en-GB" %)
204 -(% lang="en-US" style="font-family:Calibri,serif" %)Sleep apnea/apnea
204 +(% style="font-family:Calibri,serif" lang="en-US" %)Sleep apnea/apnea
205 205  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
206 206  (% class="western" lang="en-GB" %)
207 -(% lang="en-US" style="font-family:Calibri,serif" %)Mild cognitive impairment
207 +(% style="font-family:Calibri,serif" lang="en-US" %)Mild cognitive impairment
208 208  )))
209 209  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
210 210  (% class="western" lang="en-GB" %)
211 -(% lang="en-US" style="font-family:Calibri,serif" %)Chronic Obstructive Pulmonary Disease (COPD)
211 +(% style="font-family:Calibri,serif" lang="en-US" %)Chronic Obstructive Pulmonary Disease (COPD)
212 212  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
213 213  (% class="western" lang="en-GB" %)
214 -(% lang="en-US" style="font-family:Calibri,serif" %)Language disability
214 +(% style="font-family:Calibri,serif" lang="en-US" %)Language disability
215 215  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
216 216  (% class="western" lang="en-GB" %)
217 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance abuse (drugs, alcohol)
217 +(% style="font-family:Calibri,serif" lang="en-US" %)Substance abuse (drugs, alcohol)
218 218  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
219 219  (% class="western" lang="en-GB" %)
220 -(% lang="en-US" style="font-family:Calibri,serif" %)Multiple sclerosis
220 +(% style="font-family:Calibri,serif" lang="en-US" %)Multiple sclerosis
221 221  )))
222 222  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
223 223  (% class="western" lang="en-GB" %)
224 -(% lang="en-US" style="font-family:Calibri,serif" %)Cognitive disorder (mild, major)
224 +(% style="font-family:Calibri,serif" lang="en-US" %)Cognitive disorder (mild, major)
225 225  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
226 226  (% class="western" lang="en-GB" %)
227 -(% lang="en-US" style="font-family:Calibri,serif" %)Intellectual disability/ Learning difficulty/ Mental retardation
227 +(% style="font-family:Calibri,serif" lang="en-US" %)Intellectual disability/ Learning difficulty/ Mental retardation
228 228  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
229 229  (% class="western" lang="en-GB" %)
230 -(% lang="en-US" style="font-family:Calibri,serif" %)Trauma patient
230 +(% style="font-family:Calibri,serif" lang="en-US" %)Trauma patient
231 231  
232 232  (% class="western" lang="en-GB" %)
233 -(% lang="en-US" style="font-family:Calibri,serif" %)(e.g., a spinal cord injury)
233 +(% style="font-family:Calibri,serif" lang="en-US" %)(e.g., a spinal cord injury)
234 234  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
235 235  (% class="western" lang="en-GB" %)
236 -(% lang="en-US" style="font-family:Calibri,serif" %)Neurodegenerative diseases
236 +(% style="font-family:Calibri,serif" lang="en-US" %)Neurodegenerative diseases
237 237  )))
238 238  |(% style="border-bottom:none; border-left:none; border-right:none; border-top:none; height:6px; padding:0in; width:146px" %)(((
239 239  (% class="western" %)
... ... @@ -250,17 +250,17 @@
250 250  )))
251 251  |(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
252 252  (% class="western" lang="en-GB" style="text-align:center" %)
253 -(% lang="en-US" style="font-family:Calibri,serif" %)**Clients of a specific service**
253 +(% style="font-family:Calibri,serif" lang="en-US" %)**Clients of a specific service**
254 254  )))
255 255  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
256 256  (% class="western" lang="en-GB" %)
257 -(% lang="en-US" style="font-family:Calibri,serif" %)Child welfare
257 +(% style="font-family:Calibri,serif" lang="en-US" %)Child welfare
258 258  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
259 259  (% class="western" lang="en-GB" %)
260 -(% lang="en-US" style="font-family:Calibri,serif" %)Nursing home
260 +(% style="font-family:Calibri,serif" lang="en-US" %)Nursing home
261 261  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
262 262  (% class="western" lang="en-GB" %)
263 -(% lang="en-US" style="font-family:Calibri,serif" %)Employment service
263 +(% style="font-family:Calibri,serif" lang="en-US" %)Employment service
264 264  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
265 265  (% class="western" %)
266 266  
... ... @@ -267,10 +267,10 @@
267 267  )))
268 268  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:6px; padding:0in 0.08in; width:146px" %)(((
269 269  (% class="western" lang="en-GB" %)
270 -(% lang="en-US" style="font-family:Calibri,serif" %)Early childhood education
270 +(% style="font-family:Calibri,serif" lang="en-US" %)Early childhood education
271 271  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
272 272  (% class="western" lang="en-GB" %)
273 -(% lang="en-US" style="font-family:Calibri,serif" %)Home care
273 +(% style="font-family:Calibri,serif" lang="en-US" %)Home care
274 274  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
275 275  (% class="western" lang="en-GB" %)
276 276  
... ... @@ -293,56 +293,56 @@
293 293  )))
294 294  |(% colspan="4" style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; height:6px; padding:0in 0.08in; vertical-align:top; width:628px" %)(((
295 295  (% class="western" lang="en-GB" style="text-align:center" %)
296 -(% lang="en-US" style="font-family:Calibri,serif" %)**Vulnerable groups**
296 +(% style="font-family:Calibri,serif" lang="en-US" %)**Vulnerable groups**
297 297  )))
298 298  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:44px; padding:0in 0.08in; width:146px" %)(((
299 299  (% class="western" lang="en-GB" %)
300 -(% lang="en-US" style="font-family:Calibri,serif" %)Minors/Children
300 +(% style="font-family:Calibri,serif" lang="en-US" %)Minors/Children
301 301  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
302 302  (% class="western" lang="en-GB" %)
303 -(% lang="en-US" style="font-family:Calibri,serif" %)Single parents with minor children
303 +(% style="font-family:Calibri,serif" lang="en-US" %)Single parents with minor children
304 304  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
305 305  (% class="western" lang="en-GB" %)
306 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons subjected to psychological, physical or sexual violence
306 +(% style="font-family:Calibri,serif" lang="en-US" %)Persons subjected to psychological, physical or sexual violence
307 307  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
308 308  (% class="western" lang="en-GB" %)
309 -(% lang="en-US" style="font-family:Calibri,serif" %)Substance users
309 +(% style="font-family:Calibri,serif" lang="en-US" %)Substance users
310 310  
311 311  (% class="western" lang="en-GB" %)
312 -(% lang="en-US" style="font-family:Calibri,serif" %)(drugs, alcohol)
312 +(% style="font-family:Calibri,serif" lang="en-US" %)(drugs, alcohol)
313 313  )))
314 314  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
315 315  (% class="western" lang="en-GB" %)
316 -(% lang="en-US" style="font-family:Calibri,serif" %)Disabled people
316 +(% style="font-family:Calibri,serif" lang="en-US" %)Disabled people
317 317  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
318 318  (% class="western" lang="en-GB" %)
319 -(% lang="en-US" style="font-family:Calibri,serif" %)Victims of trafficking in human beings
319 +(% style="font-family:Calibri,serif" lang="en-US" %)Victims of trafficking in human beings
320 320  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
321 321  (% class="western" lang="en-GB" %)
322 -(% lang="en-US" style="font-family:Calibri,serif" %)Ethnic minorities and immigrants
322 +(% style="font-family:Calibri,serif" lang="en-US" %)Ethnic minorities and immigrants
323 323  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
324 324  (% class="western" lang="en-GB" %)
325 -(% lang="en-US" style="font-family:Calibri,serif" %)Isolated people
325 +(% style="font-family:Calibri,serif" lang="en-US" %)Isolated people
326 326  )))
327 327  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:24px; padding:0in 0.08in; width:146px" %)(((
328 328  (% class="western" lang="en-GB" %)
329 -(% lang="en-US" style="font-family:Calibri,serif" %)Elderly people
329 +(% style="font-family:Calibri,serif" lang="en-US" %)Elderly people
330 330  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
331 331  (% class="western" lang="en-GB" %)
332 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with serious illnesses
332 +(% style="font-family:Calibri,serif" lang="en-US" %)Persons with serious illnesses
333 333  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
334 334  (% class="western" lang="en-GB" %)
335 -(% lang="en-US" style="font-family:Calibri,serif" %)Homeless people
335 +(% style="font-family:Calibri,serif" lang="en-US" %)Homeless people
336 336  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:147px" %)(((
337 337  (% class="western" lang="en-GB" %)
338 -(% lang="en-US" style="font-family:Calibri,serif" %)Ex-prisoners and people with criminal background
338 +(% style="font-family:Calibri,serif" lang="en-US" %)Ex-prisoners and people with criminal background
339 339  )))
340 340  |(% style="border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:none; height:5px; padding:0in 0.08in; width:146px" %)(((
341 341  (% class="western" lang="en-GB" %)
342 -(% lang="en-US" style="font-family:Calibri,serif" %)Pregnant women
342 +(% style="font-family:Calibri,serif" lang="en-US" %)Pregnant women
343 343  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
344 344  (% class="western" lang="en-GB" %)
345 -(% lang="en-US" style="font-family:Calibri,serif" %)Persons with mental disorders
345 +(% style="font-family:Calibri,serif" lang="en-US" %)Persons with mental disorders
346 346  )))|(% style="border-bottom:1px solid #000000; border-left:none; border-right:1px solid #000000; border-top:none; padding-bottom:0in; padding-left:0in; padding-right:0.08in; padding-top:0in; width:146px" %)(((
347 347  (% class="western" lang="en-GB" %)
348 348  
... ... @@ -352,7 +352,7 @@
352 352  )))
353 353  
354 354  (% class="western" lang="en-GB" %)
355 -(% lang="en-US" style="page-break-before:always" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
355 +(% style="page-break-before:always" lang="en-US" %)Living lab research infrastructure end users and B2B-customers (% style="page-break-before:always" %)in health and wellbeing living lab projects are presented in Table .
356 356  
357 357  
358 358  |**Researcher expertise**|**Brief use case description**

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101007990

Copyright © 2021 VITALISE Project